1-(4-Methoxyphenyl)-4-(4-nitrophenyl)piperazine

Catalog No.: 
ACZWAG510
CAS No.: 
74852-61-2
Molecular Formula: 
C17H19N3O3
Molecular Weight: 
313.36
1-(4-Methoxyphenyl)-4-(4-nitrophenyl)piperazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%
1g97%
5g97%
25g97%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(4-Methoxyphenyl)-4-(4-nitrophenyl)piperazine
IUPAC Name1-(4-methoxyphenyl)-4-(4-nitrophenyl)piperazine
Molecular FormulaC17H19N3O3
Molecular Weight313.36
SMILESO=[N+](C1=CC=C(N2CCN(C3=CC=C(OC)C=C3)CC2)C=C1)[O-]
InChI KeyAVCKOFMRPAJEPN-UHFFFAOYSA-N
Synonym1-(4-METHYLOXY-PHENYL)-4-(4-NITRO-PHENYL)-PIPERAZINE;1-(4-METHOXYPHENYL)-4-(4-NITROPHENYL)PIPERAZINE;1-(4-Methoxyphonyl)-4-(4-Nitrophenyl)Piperazine;PIPERAZINE,1-(4-METHOXYPHENYL)-4-(4-NITROPHENYL)-;1-(4-METHOXYPHENYL)-4-ITROPHENYL)PIPERAZINE;1-(4-Methoxyphenyl)-4-(4 -nitrophenyl) piperazine (IT – I)-S;1-(-4-Methoxy Phenyl)-4-(-4-Nitro Phenyl) Piperazine (Nitro)
CAS No.74852-61-2
PubChem CID5134657

Synthetic Route by SureRoute

1. ACZWAG510 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZWAG510 route product structure diagram
    ACZWAG51074852-61-2In Stock
Inquiry

2. ACZWAG510 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZWAG510 route product structure diagram
    ACZWAG51074852-61-2In Stock
Inquiry

3. ACZWAG510 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZWAG510 route product structure diagram
    ACZWAG51074852-61-2In Stock
Inquiry

Comments (0)